N.O. Biotech Firm Buys Technology, Facility from Minnesota Company

Biotech firm AxoSim, which provides pharmaceutical companies a high-tech alternative to animal testing, announced that it has acquired several assets of a Minneapolis-based company in the same field. AxoSim has acquired from StemoniX (a subsidiary of Vyant Bio) a proprietary drug discovery platform, a 14,000-square-foot R&D facility, nine patents and associated intellectual property. The transaction calls for payments from AxoSim to Vyant Bio of $2.25 million. About half was paid at close and the remainder will be based on milestones.

Read the full article: N.O. Biotech Firm Buys Technology, Facility from Minnesota Company //

Source: https://www.bizneworleans.com/n-o-biotech-firm-buys-technology-facility-from-minnesota-company

Leave a Comment

Your email address will not be published.

Scroll to Top